SEMAGLUTIDE KITS

Description

Semaglutide

Semaglutide is a synthetic peptide analog of glucagon-like peptide-1, commonly known as GLP-1. It is studied for its interaction with GLP-1 receptors and its effects on receptor signaling, glucose-related pathways, appetite regulation, gastric function, and metabolic processes.

Researchers may use semaglutide in controlled laboratory environments to investigate GLP-1 receptor activity, peptide-receptor interactions, endocrine signaling, cellular communication, and metabolic pathway behavior. FDA-approved prescription medicines containing semaglutide exist, but separately supplied research material must not be represented as an approved drug or as suitable for medical use.

Research Applications

• GLP-1 receptor interaction studies
• Endocrine and metabolic pathway research
• Glucose-signaling investigations
• Appetite and energy-balance research
• Cellular signaling studies
• Experimental peptide characterization

Product Specifications

Compound: Semaglutide
Category: Synthetic Research Peptide
Classification: GLP-1 Receptor Agonist Research Compound
Form: Lyophilized Powder
Purity: Refer to the current Certificate of Analysis
Intended Use: Laboratory research and analytical applications

Research Use Only

This product is supplied exclusively for legitimate laboratory research and analytical purposes. It is intended only for use by qualified professionals in controlled research environments.

Not intended for human or veterinary use, consumption, injection, administration, diagnosis, treatment, weight management, or therapeutic purposes. This research product is not represented as Ozempic, Wegovy, Rybelsus, or any other FDA-approved medication. The FDA warns that unapproved semaglutide products are not reviewed for safety, effectiveness, or quality before marketing.